At a glance
- Originator Almirall-Prodesfarma
- Class Ischaemic heart disorder therapies; Nitro compounds; Phenoxypropanolamines; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists; Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Hypertension